Fisher & Paykel Healthcare Corporation Limited reported revenue results for the first four months ended 31 July 2021. Revenue for the first four months was $583 million, with 74% of revenue from the company's Hospital product group and 26% from its Homecare product group. In constant currency, revenue for the four months was 2% below the prior comparable period, which was a period of high demand during the initial surges of COVID-19 in North America and Europe.